nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR2—stomach cancer	0.374	1	CbGaD
Pazopanib—UGT1A1—Irinotecan—stomach cancer	0.0354	0.158	CbGbCtD
Pazopanib—ABCB1—Mitomycin—stomach cancer	0.0274	0.122	CbGbCtD
Pazopanib—SLCO1B1—Irinotecan—stomach cancer	0.0245	0.109	CbGbCtD
Pazopanib—ABCG2—Irinotecan—stomach cancer	0.0195	0.0868	CbGbCtD
Pazopanib—ABCG2—Fluorouracil—stomach cancer	0.0187	0.0833	CbGbCtD
Pazopanib—ABCG2—Docetaxel—stomach cancer	0.0143	0.0636	CbGbCtD
Pazopanib—SLCO1B1—Methotrexate—stomach cancer	0.013	0.0578	CbGbCtD
Pazopanib—ABCG2—Doxorubicin—stomach cancer	0.0106	0.0474	CbGbCtD
Pazopanib—ABCG2—Methotrexate—stomach cancer	0.0103	0.046	CbGbCtD
Pazopanib—CYP2C8—Fluorouracil—stomach cancer	0.00996	0.0444	CbGbCtD
Pazopanib—CYP1A2—Fluorouracil—stomach cancer	0.00771	0.0344	CbGbCtD
Pazopanib—ABCB1—Irinotecan—stomach cancer	0.00702	0.0313	CbGbCtD
Pazopanib—ABCB1—Docetaxel—stomach cancer	0.00515	0.0229	CbGbCtD
Pazopanib—CYP3A4—Irinotecan—stomach cancer	0.00421	0.0188	CbGbCtD
Pazopanib—ABCB1—Doxorubicin—stomach cancer	0.00384	0.0171	CbGbCtD
Pazopanib—KIT—myenteric nerve plexus—stomach cancer	0.00373	0.0389	CbGeAlD
Pazopanib—ABCB1—Methotrexate—stomach cancer	0.00372	0.0166	CbGbCtD
Pazopanib—CYP2D6—Doxorubicin—stomach cancer	0.00362	0.0161	CbGbCtD
Pazopanib—CYP3A4—Docetaxel—stomach cancer	0.00308	0.0137	CbGbCtD
Pazopanib—CYP3A4—Doxorubicin—stomach cancer	0.0023	0.0102	CbGbCtD
Pazopanib—PLK4—Topotecan—Irinotecan—stomach cancer	0.00142	0.525	CbGdCrCtD
Pazopanib—MAP3K9—epithelium—stomach cancer	0.00138	0.0144	CbGeAlD
Pazopanib—FLT4—blood vessel—stomach cancer	0.00131	0.0136	CbGeAlD
Pazopanib—ITK—hematopoietic system—stomach cancer	0.00125	0.013	CbGeAlD
Pazopanib—MAP3K9—pancreas—stomach cancer	0.00123	0.0128	CbGeAlD
Pazopanib—FGF1—blood vessel—stomach cancer	0.00116	0.0121	CbGeAlD
Pazopanib—TAOK1—hematopoietic system—stomach cancer	0.00113	0.0118	CbGeAlD
Pazopanib—SH2B3—hematopoietic system—stomach cancer	0.00107	0.0111	CbGeAlD
Pazopanib—MAP3K9—digestive system—stomach cancer	0.00105	0.0109	CbGeAlD
Pazopanib—FLT1—blood vessel—stomach cancer	0.00102	0.0106	CbGeAlD
Pazopanib—PLK4—hematopoietic system—stomach cancer	0.000961	0.01	CbGeAlD
Pazopanib—STK16—hematopoietic system—stomach cancer	0.000907	0.00946	CbGeAlD
Pazopanib—LYN—hematopoietic system—stomach cancer	0.000898	0.00936	CbGeAlD
Pazopanib—PDGFRA—gall bladder—stomach cancer	0.000897	0.00936	CbGeAlD
Pazopanib—FGFR3—hematopoietic system—stomach cancer	0.000893	0.00931	CbGeAlD
Pazopanib—ITK—lymphoid tissue—stomach cancer	0.000877	0.00914	CbGeAlD
Pazopanib—SH2B3—pancreas—stomach cancer	0.000869	0.00906	CbGeAlD
Pazopanib—KDR—blood vessel—stomach cancer	0.00086	0.00897	CbGeAlD
Pazopanib—FGFR3—epithelium—stomach cancer	0.000817	0.00851	CbGeAlD
Pazopanib—BMPR1B—epithelium—stomach cancer	0.000808	0.00843	CbGeAlD
Pazopanib—ITK—bone marrow—stomach cancer	0.000798	0.00832	CbGeAlD
Pazopanib—MAP3K9—liver—stomach cancer	0.000782	0.00815	CbGeAlD
Pazopanib—LIMK2—hematopoietic system—stomach cancer	0.000776	0.00809	CbGeAlD
Pazopanib—KIT—blood vessel—stomach cancer	0.000762	0.00795	CbGeAlD
Pazopanib—SH2B3—lymphoid tissue—stomach cancer	0.000751	0.00783	CbGeAlD
Pazopanib—PDGFRB—blood vessel—stomach cancer	0.000745	0.00776	CbGeAlD
Pazopanib—TAOK1—bone marrow—stomach cancer	0.000727	0.00758	CbGeAlD
Pazopanib—KIT—gall bladder—stomach cancer	0.000717	0.00748	CbGeAlD
Pazopanib—ITK—endocrine gland—stomach cancer	0.000716	0.00746	CbGeAlD
Pazopanib—PDGFRB—gall bladder—stomach cancer	0.000701	0.0073	CbGeAlD
Pazopanib—FLT4—hematopoietic system—stomach cancer	0.000697	0.00727	CbGeAlD
Pazopanib—PI4KB—smooth muscle tissue—stomach cancer	0.000696	0.00725	CbGeAlD
Pazopanib—SH2B3—bone marrow—stomach cancer	0.000684	0.00713	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—stomach cancer	0.000676	0.00705	CbGeAlD
Pazopanib—MAP3K2—hematopoietic system—stomach cancer	0.000657	0.00685	CbGeAlD
Pazopanib—TAOK1—endocrine gland—stomach cancer	0.000651	0.00679	CbGeAlD
Pazopanib—PI4KB—pancreas—stomach cancer	0.000643	0.00671	CbGeAlD
Pazopanib—STK16—lymphoid tissue—stomach cancer	0.000639	0.00666	CbGeAlD
Pazopanib—FLT4—epithelium—stomach cancer	0.000637	0.00664	CbGeAlD
Pazopanib—LYN—lymphoid tissue—stomach cancer	0.000632	0.00659	CbGeAlD
Pazopanib—STK16—digestive system—stomach cancer	0.000631	0.00658	CbGeAlD
Pazopanib—FGF1—hematopoietic system—stomach cancer	0.000619	0.00645	CbGeAlD
Pazopanib—PLK4—bone marrow—stomach cancer	0.000616	0.00642	CbGeAlD
Pazopanib—AURKC—endocrine gland—stomach cancer	0.000604	0.00629	CbGeAlD
Pazopanib—MAP3K9—lymph node—stomach cancer	0.0006	0.00625	CbGeAlD
Pazopanib—TAOK1—liver—stomach cancer	0.000587	0.00612	CbGeAlD
Pazopanib—FGFR2—hematopoietic system—stomach cancer	0.000585	0.0061	CbGeAlD
Pazopanib—RIOK2—bone marrow—stomach cancer	0.000573	0.00597	CbGeAlD
Pazopanib—FGF1—epithelium—stomach cancer	0.000566	0.0059	CbGeAlD
Pazopanib—PIP4K2C—pancreas—stomach cancer	0.000565	0.00588	CbGeAlD
Pazopanib—SH2B3—liver—stomach cancer	0.000553	0.00576	CbGeAlD
Pazopanib—PLK4—endocrine gland—stomach cancer	0.000552	0.00576	CbGeAlD
Pazopanib—LIMK2—lymphoid tissue—stomach cancer	0.000546	0.00569	CbGeAlD
Pazopanib—FGF1—smooth muscle tissue—stomach cancer	0.000545	0.00569	CbGeAlD
Pazopanib—FLT1—hematopoietic system—stomach cancer	0.000542	0.00565	CbGeAlD
Pazopanib—FGFR2—epithelium—stomach cancer	0.000534	0.00557	CbGeAlD
Pazopanib—STK16—endocrine gland—stomach cancer	0.000521	0.00544	CbGeAlD
Pazopanib—LYN—endocrine gland—stomach cancer	0.000516	0.00538	CbGeAlD
Pazopanib—FGFR2—smooth muscle tissue—stomach cancer	0.000515	0.00537	CbGeAlD
Pazopanib—FGFR3—endocrine gland—stomach cancer	0.000513	0.00535	CbGeAlD
Pazopanib—STK10—hematopoietic system—stomach cancer	0.000513	0.00535	CbGeAlD
Pazopanib—TAOK3—hematopoietic system—stomach cancer	0.000511	0.00533	CbGeAlD
Pazopanib—BMPR1B—endocrine gland—stomach cancer	0.000508	0.0053	CbGeAlD
Pazopanib—PDGFRA—hematopoietic system—stomach cancer	0.000508	0.00529	CbGeAlD
Pazopanib—PI4KB—bone marrow—stomach cancer	0.000507	0.00528	CbGeAlD
Pazopanib—FLT1—epithelium—stomach cancer	0.000495	0.00516	CbGeAlD
Pazopanib—ITK—lymph node—stomach cancer	0.000495	0.00516	CbGeAlD
Pazopanib—FLT4—lymphoid tissue—stomach cancer	0.000491	0.00512	CbGeAlD
Pazopanib—UGT1A1—hematopoietic system—stomach cancer	0.000485	0.00505	CbGeAlD
Pazopanib—FLT1—smooth muscle tissue—stomach cancer	0.000477	0.00498	CbGeAlD
Pazopanib—STK16—liver—stomach cancer	0.00047	0.0049	CbGeAlD
Pazopanib—LYN—liver—stomach cancer	0.000465	0.00485	CbGeAlD
Pazopanib—FGFR3—liver—stomach cancer	0.000463	0.00482	CbGeAlD
Pazopanib—RIOK2—liver—stomach cancer	0.000463	0.00482	CbGeAlD
Pazopanib—MAP3K2—lymphoid tissue—stomach cancer	0.000463	0.00482	CbGeAlD
Pazopanib—STK36—endocrine gland—stomach cancer	0.000461	0.00481	CbGeAlD
Pazopanib—KDR—hematopoietic system—stomach cancer	0.000458	0.00478	CbGeAlD
Pazopanib—PI4KB—endocrine gland—stomach cancer	0.000454	0.00473	CbGeAlD
Pazopanib—TAOK1—lymph node—stomach cancer	0.00045	0.00469	CbGeAlD
Pazopanib—PDGFRA—smooth muscle tissue—stomach cancer	0.000447	0.00466	CbGeAlD
Pazopanib—CSF1R—hematopoietic system—stomach cancer	0.000447	0.00466	CbGeAlD
Pazopanib—FLT4—bone marrow—stomach cancer	0.000447	0.00466	CbGeAlD
Pazopanib—LIMK2—endocrine gland—stomach cancer	0.000446	0.00465	CbGeAlD
Pazopanib—PIP4K2C—bone marrow—stomach cancer	0.000444	0.00463	CbGeAlD
Pazopanib—FLT1—pancreas—stomach cancer	0.000441	0.0046	CbGeAlD
Pazopanib—FGF1—lymphoid tissue—stomach cancer	0.000436	0.00454	CbGeAlD
Pazopanib—FGF1—digestive system—stomach cancer	0.000431	0.00449	CbGeAlD
Pazopanib—SH2B3—lymph node—stomach cancer	0.000424	0.00442	CbGeAlD
Pazopanib—MAP3K2—bone marrow—stomach cancer	0.000421	0.00439	CbGeAlD
Pazopanib—KDR—epithelium—stomach cancer	0.000419	0.00437	CbGeAlD
Pazopanib—AURKC—lymph node—stomach cancer	0.000417	0.00435	CbGeAlD
Pazopanib—TAOK3—pancreas—stomach cancer	0.000416	0.00434	CbGeAlD
Pazopanib—STK36—liver—stomach cancer	0.000416	0.00433	CbGeAlD
Pazopanib—PI4KB—liver—stomach cancer	0.000409	0.00427	CbGeAlD
Pazopanib—FGFR2—digestive system—stomach cancer	0.000407	0.00424	CbGeAlD
Pazopanib—KIT—hematopoietic system—stomach cancer	0.000406	0.00423	CbGeAlD
Pazopanib—KDR—smooth muscle tissue—stomach cancer	0.000404	0.00421	CbGeAlD
Pazopanib—SLCO1B1—hematopoietic system—stomach cancer	0.000403	0.0042	CbGeAlD
Pazopanib—LIMK2—liver—stomach cancer	0.000402	0.00419	CbGeAlD
Pazopanib—FLT4—endocrine gland—stomach cancer	0.000401	0.00418	CbGeAlD
Pazopanib—PIP4K2C—endocrine gland—stomach cancer	0.000398	0.00415	CbGeAlD
Pazopanib—PDGFRB—hematopoietic system—stomach cancer	0.000397	0.00413	CbGeAlD
Pazopanib—LCK—bone marrow—stomach cancer	0.000395	0.00411	CbGeAlD
Pazopanib—CSF1R—smooth muscle tissue—stomach cancer	0.000394	0.00411	CbGeAlD
Pazopanib—PLK4—lymph node—stomach cancer	0.000382	0.00398	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—stomach cancer	0.000382	0.00398	CbGeAlD
Pazopanib—MAP3K2—endocrine gland—stomach cancer	0.000378	0.00394	CbGeAlD
Pazopanib—FLT1—digestive system—stomach cancer	0.000377	0.00393	CbGeAlD
Pazopanib—KIT—epithelium—stomach cancer	0.000371	0.00387	CbGeAlD
Pazopanib—PDGFRB—epithelium—stomach cancer	0.000362	0.00378	CbGeAlD
Pazopanib—STK10—lymphoid tissue—stomach cancer	0.000361	0.00377	CbGeAlD
Pazopanib—FLT4—liver—stomach cancer	0.000361	0.00376	CbGeAlD
Pazopanib—STK16—lymph node—stomach cancer	0.00036	0.00376	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—stomach cancer	0.00036	0.00375	CbGeAlD
Pazopanib—PIP4K2C—liver—stomach cancer	0.000359	0.00374	CbGeAlD
Pazopanib—KIT—smooth muscle tissue—stomach cancer	0.000358	0.00373	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—stomach cancer	0.000358	0.00373	CbGeAlD
Pazopanib—STK10—digestive system—stomach cancer	0.000357	0.00372	CbGeAlD
Pazopanib—FGFR1—liver—stomach cancer	0.000356	0.00371	CbGeAlD
Pazopanib—FGF1—endocrine gland—stomach cancer	0.000356	0.00371	CbGeAlD
Pazopanib—TAOK3—digestive system—stomach cancer	0.000355	0.00371	CbGeAlD
Pazopanib—RIOK2—lymph node—stomach cancer	0.000355	0.0037	CbGeAlD
Pazopanib—PDGFRA—digestive system—stomach cancer	0.000353	0.00368	CbGeAlD
Pazopanib—BMPR1B—lymph node—stomach cancer	0.000351	0.00366	CbGeAlD
Pazopanib—PDGFRB—smooth muscle tissue—stomach cancer	0.000349	0.00364	CbGeAlD
Pazopanib—MAP3K2—liver—stomach cancer	0.00034	0.00355	CbGeAlD
Pazopanib—UGT1A1—digestive system—stomach cancer	0.000337	0.00351	CbGeAlD
Pazopanib—FGFR2—endocrine gland—stomach cancer	0.000336	0.0035	CbGeAlD
Pazopanib—PLK4—Doxorubicin—Epirubicin—stomach cancer	0.000335	0.123	CbGdCrCtD
Pazopanib—PLK4—Idarubicin—Epirubicin—stomach cancer	0.000335	0.123	CbGdCrCtD
Pazopanib—KIT—pancreas—stomach cancer	0.000331	0.00345	CbGeAlD
Pazopanib—STK10—bone marrow—stomach cancer	0.000329	0.00343	CbGeAlD
Pazopanib—TAOK3—bone marrow—stomach cancer	0.000328	0.00342	CbGeAlD
Pazopanib—PDGFRB—pancreas—stomach cancer	0.000323	0.00337	CbGeAlD
Pazopanib—KDR—lymphoid tissue—stomach cancer	0.000323	0.00336	CbGeAlD
Pazopanib—FGF1—liver—stomach cancer	0.000321	0.00334	CbGeAlD
Pazopanib—LCK—liver—stomach cancer	0.000319	0.00332	CbGeAlD
Pazopanib—STK36—lymph node—stomach cancer	0.000319	0.00332	CbGeAlD
Pazopanib—KDR—digestive system—stomach cancer	0.000319	0.00332	CbGeAlD
Pazopanib—CSF1R—lymphoid tissue—stomach cancer	0.000315	0.00328	CbGeAlD
Pazopanib—PI4KB—lymph node—stomach cancer	0.000314	0.00327	CbGeAlD
Pazopanib—FLT1—endocrine gland—stomach cancer	0.000311	0.00325	CbGeAlD
Pazopanib—CSF1R—digestive system—stomach cancer	0.000311	0.00324	CbGeAlD
Pazopanib—PLK4—Epirubicin—Doxorubicin—stomach cancer	0.00031	0.114	CbGdCrCtD
Pazopanib—PLK4—Idarubicin—Doxorubicin—stomach cancer	0.00031	0.114	CbGdCrCtD
Pazopanib—LIMK2—lymph node—stomach cancer	0.000308	0.00321	CbGeAlD
Pazopanib—FGFR2—liver—stomach cancer	0.000303	0.00316	CbGeAlD
Pazopanib—STK10—endocrine gland—stomach cancer	0.000295	0.00307	CbGeAlD
Pazopanib—KDR—bone marrow—stomach cancer	0.000294	0.00306	CbGeAlD
Pazopanib—TAOK3—endocrine gland—stomach cancer	0.000294	0.00306	CbGeAlD
Pazopanib—PDGFRA—endocrine gland—stomach cancer	0.000292	0.00304	CbGeAlD
Pazopanib—CSF1R—bone marrow—stomach cancer	0.000287	0.00299	CbGeAlD
Pazopanib—KIT—lymphoid tissue—stomach cancer	0.000286	0.00298	CbGeAlD
Pazopanib—KIT—digestive system—stomach cancer	0.000282	0.00294	CbGeAlD
Pazopanib—FLT1—liver—stomach cancer	0.000281	0.00293	CbGeAlD
Pazopanib—SLCO1B1—digestive system—stomach cancer	0.00028	0.00292	CbGeAlD
Pazopanib—PDGFRB—lymphoid tissue—stomach cancer	0.000279	0.00291	CbGeAlD
Pazopanib—UGT1A1—endocrine gland—stomach cancer	0.000278	0.0029	CbGeAlD
Pazopanib—FLT4—lymph node—stomach cancer	0.000277	0.00289	CbGeAlD
Pazopanib—PDGFRB—digestive system—stomach cancer	0.000276	0.00287	CbGeAlD
Pazopanib—PIP4K2C—lymph node—stomach cancer	0.000275	0.00287	CbGeAlD
Pazopanib—FGFR1—lymph node—stomach cancer	0.000273	0.00285	CbGeAlD
Pazopanib—STK10—liver—stomach cancer	0.000266	0.00277	CbGeAlD
Pazopanib—TAOK3—liver—stomach cancer	0.000265	0.00276	CbGeAlD
Pazopanib—KDR—endocrine gland—stomach cancer	0.000263	0.00274	CbGeAlD
Pazopanib—MAP2K5—endocrine gland—stomach cancer	0.000263	0.00274	CbGeAlD
Pazopanib—PDGFRA—liver—stomach cancer	0.000263	0.00274	CbGeAlD
Pazopanib—MAP3K2—lymph node—stomach cancer	0.000261	0.00272	CbGeAlD
Pazopanib—KIT—bone marrow—stomach cancer	0.00026	0.00271	CbGeAlD
Pazopanib—CSF1R—endocrine gland—stomach cancer	0.000257	0.00268	CbGeAlD
Pazopanib—PDGFRB—bone marrow—stomach cancer	0.000254	0.00265	CbGeAlD
Pazopanib—UGT1A1—liver—stomach cancer	0.000251	0.00262	CbGeAlD
Pazopanib—FGF1—lymph node—stomach cancer	0.000246	0.00256	CbGeAlD
Pazopanib—LCK—lymph node—stomach cancer	0.000244	0.00255	CbGeAlD
Pazopanib—KDR—liver—stomach cancer	0.000237	0.00247	CbGeAlD
Pazopanib—MAP2K5—liver—stomach cancer	0.000237	0.00247	CbGeAlD
Pazopanib—KIT—endocrine gland—stomach cancer	0.000233	0.00243	CbGeAlD
Pazopanib—SLCO1B1—endocrine gland—stomach cancer	0.000232	0.00242	CbGeAlD
Pazopanib—CSF1R—liver—stomach cancer	0.000232	0.00241	CbGeAlD
Pazopanib—CYP2C8—hematopoietic system—stomach cancer	0.000229	0.00239	CbGeAlD
Pazopanib—PDGFRB—endocrine gland—stomach cancer	0.000228	0.00238	CbGeAlD
Pazopanib—FLT1—lymph node—stomach cancer	0.000215	0.00224	CbGeAlD
Pazopanib—CYP1A2—hematopoietic system—stomach cancer	0.000215	0.00224	CbGeAlD
Pazopanib—EPHB6—lymph node—stomach cancer	0.000213	0.00222	CbGeAlD
Pazopanib—KIT—liver—stomach cancer	0.00021	0.00219	CbGeAlD
Pazopanib—SLCO1B1—liver—stomach cancer	0.000209	0.00218	CbGeAlD
Pazopanib—ABCB1—blood vessel—stomach cancer	0.000206	0.00215	CbGeAlD
Pazopanib—PDGFRB—liver—stomach cancer	0.000205	0.00214	CbGeAlD
Pazopanib—STK10—lymph node—stomach cancer	0.000204	0.00212	CbGeAlD
Pazopanib—TAOK3—lymph node—stomach cancer	0.000203	0.00212	CbGeAlD
Pazopanib—PDGFRA—lymph node—stomach cancer	0.000202	0.0021	CbGeAlD
Pazopanib—KDR—lymph node—stomach cancer	0.000182	0.0019	CbGeAlD
Pazopanib—MAP2K5—lymph node—stomach cancer	0.000182	0.0019	CbGeAlD
Pazopanib—CSF1R—lymph node—stomach cancer	0.000178	0.00185	CbGeAlD
Pazopanib—KIT—lymph node—stomach cancer	0.000161	0.00168	CbGeAlD
Pazopanib—PDGFRB—lymph node—stomach cancer	0.000158	0.00164	CbGeAlD
Pazopanib—CYP3A4—hematopoietic system—stomach cancer	0.000155	0.00162	CbGeAlD
Pazopanib—CYP2D6—hematopoietic system—stomach cancer	0.000153	0.00159	CbGeAlD
Pazopanib—CYP1A2—digestive system—stomach cancer	0.000149	0.00156	CbGeAlD
Pazopanib—ABCG2—bone marrow—stomach cancer	0.000143	0.00149	CbGeAlD
Pazopanib—CYP2C8—endocrine gland—stomach cancer	0.000132	0.00137	CbGeAlD
Pazopanib—CYP1A2—endocrine gland—stomach cancer	0.000123	0.00129	CbGeAlD
Pazopanib—CYP2C8—liver—stomach cancer	0.000119	0.00124	CbGeAlD
Pazopanib—ABCG2—liver—stomach cancer	0.000115	0.0012	CbGeAlD
Pazopanib—CYP1A2—liver—stomach cancer	0.000111	0.00116	CbGeAlD
Pazopanib—ABCB1—hematopoietic system—stomach cancer	0.00011	0.00115	CbGeAlD
Pazopanib—CYP3A4—digestive system—stomach cancer	0.000108	0.00113	CbGeAlD
Pazopanib—CYP2D6—digestive system—stomach cancer	0.000106	0.00111	CbGeAlD
Pazopanib—ABCB1—epithelium—stomach cancer	0.0001	0.00105	CbGeAlD
Pazopanib—ABCB1—pancreas—stomach cancer	8.95e-05	0.000933	CbGeAlD
Pazopanib—CYP3A4—endocrine gland—stomach cancer	8.92e-05	0.00093	CbGeAlD
Pazopanib—ABCG2—lymph node—stomach cancer	8.85e-05	0.000923	CbGeAlD
Pazopanib—CYP2D6—endocrine gland—stomach cancer	8.78e-05	0.000915	CbGeAlD
Pazopanib—CYP3A4—liver—stomach cancer	8.04e-05	0.000839	CbGeAlD
Pazopanib—CYP2D6—liver—stomach cancer	7.92e-05	0.000825	CbGeAlD
Pazopanib—ABCB1—lymphoid tissue—stomach cancer	7.74e-05	0.000807	CbGeAlD
Pazopanib—ABCB1—digestive system—stomach cancer	7.64e-05	0.000797	CbGeAlD
Pazopanib—Epistaxis—Epirubicin—stomach cancer	7.28e-05	0.000537	CcSEcCtD
Pazopanib—Urethral disorder—Methotrexate—stomach cancer	7.25e-05	0.000536	CcSEcCtD
Pazopanib—Infection—Docetaxel—stomach cancer	7.25e-05	0.000535	CcSEcCtD
Pazopanib—Weight decreased—Doxorubicin—stomach cancer	7.24e-05	0.000535	CcSEcCtD
Pazopanib—Diarrhoea—Irinotecan—stomach cancer	7.22e-05	0.000533	CcSEcCtD
Pazopanib—Dry mouth—Capecitabine—stomach cancer	7.2e-05	0.000532	CcSEcCtD
Pazopanib—Shock—Docetaxel—stomach cancer	7.18e-05	0.00053	CcSEcCtD
Pazopanib—Nervous system disorder—Docetaxel—stomach cancer	7.15e-05	0.000528	CcSEcCtD
Pazopanib—Pruritus—Fluorouracil—stomach cancer	7.15e-05	0.000528	CcSEcCtD
Pazopanib—Thrombocytopenia—Docetaxel—stomach cancer	7.14e-05	0.000527	CcSEcCtD
Pazopanib—Infestation—Doxorubicin—stomach cancer	7.14e-05	0.000527	CcSEcCtD
Pazopanib—Infestation NOS—Doxorubicin—stomach cancer	7.14e-05	0.000527	CcSEcCtD
Pazopanib—Skin disorder—Docetaxel—stomach cancer	7.08e-05	0.000523	CcSEcCtD
Pazopanib—Oedema—Capecitabine—stomach cancer	7.06e-05	0.000522	CcSEcCtD
Pazopanib—Bradycardia—Epirubicin—stomach cancer	7.05e-05	0.000521	CcSEcCtD
Pazopanib—ABCB1—bone marrow—stomach cancer	7.05e-05	0.000735	CbGeAlD
Pazopanib—Infection—Capecitabine—stomach cancer	7.02e-05	0.000518	CcSEcCtD
Pazopanib—Dizziness—Irinotecan—stomach cancer	6.98e-05	0.000515	CcSEcCtD
Pazopanib—Haemoglobin—Epirubicin—stomach cancer	6.96e-05	0.000514	CcSEcCtD
Pazopanib—Jaundice—Doxorubicin—stomach cancer	6.96e-05	0.000514	CcSEcCtD
Pazopanib—Stomatitis—Doxorubicin—stomach cancer	6.96e-05	0.000514	CcSEcCtD
Pazopanib—Anorexia—Docetaxel—stomach cancer	6.95e-05	0.000513	CcSEcCtD
Pazopanib—Shock—Capecitabine—stomach cancer	6.95e-05	0.000513	CcSEcCtD
Pazopanib—Nervous system disorder—Capecitabine—stomach cancer	6.92e-05	0.000511	CcSEcCtD
Pazopanib—Haemorrhage—Epirubicin—stomach cancer	6.92e-05	0.000511	CcSEcCtD
Pazopanib—Eye disorder—Methotrexate—stomach cancer	6.91e-05	0.000511	CcSEcCtD
Pazopanib—Diarrhoea—Fluorouracil—stomach cancer	6.91e-05	0.000511	CcSEcCtD
Pazopanib—Thrombocytopenia—Capecitabine—stomach cancer	6.91e-05	0.000511	CcSEcCtD
Pazopanib—Hypoaesthesia—Epirubicin—stomach cancer	6.89e-05	0.000509	CcSEcCtD
Pazopanib—Cardiac disorder—Methotrexate—stomach cancer	6.87e-05	0.000507	CcSEcCtD
Pazopanib—Skin disorder—Capecitabine—stomach cancer	6.86e-05	0.000507	CcSEcCtD
Pazopanib—Urinary tract disorder—Epirubicin—stomach cancer	6.84e-05	0.000505	CcSEcCtD
Pazopanib—Hyperhidrosis—Capecitabine—stomach cancer	6.83e-05	0.000504	CcSEcCtD
Pazopanib—Oedema peripheral—Epirubicin—stomach cancer	6.82e-05	0.000504	CcSEcCtD
Pazopanib—Haematuria—Doxorubicin—stomach cancer	6.8e-05	0.000503	CcSEcCtD
Pazopanib—Connective tissue disorder—Epirubicin—stomach cancer	6.8e-05	0.000503	CcSEcCtD
Pazopanib—Urethral disorder—Epirubicin—stomach cancer	6.79e-05	0.000501	CcSEcCtD
Pazopanib—Hepatobiliary disease—Doxorubicin—stomach cancer	6.75e-05	0.000499	CcSEcCtD
Pazopanib—Epistaxis—Doxorubicin—stomach cancer	6.73e-05	0.000497	CcSEcCtD
Pazopanib—Anorexia—Capecitabine—stomach cancer	6.73e-05	0.000497	CcSEcCtD
Pazopanib—Angiopathy—Methotrexate—stomach cancer	6.71e-05	0.000496	CcSEcCtD
Pazopanib—Vomiting—Irinotecan—stomach cancer	6.71e-05	0.000495	CcSEcCtD
Pazopanib—Dizziness—Fluorouracil—stomach cancer	6.68e-05	0.000494	CcSEcCtD
Pazopanib—Mediastinal disorder—Methotrexate—stomach cancer	6.67e-05	0.000492	CcSEcCtD
Pazopanib—Rash—Irinotecan—stomach cancer	6.65e-05	0.000491	CcSEcCtD
Pazopanib—Dermatitis—Irinotecan—stomach cancer	6.65e-05	0.000491	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.64e-05	0.000491	CcSEcCtD
Pazopanib—Chills—Methotrexate—stomach cancer	6.64e-05	0.00049	CcSEcCtD
Pazopanib—Headache—Irinotecan—stomach cancer	6.61e-05	0.000488	CcSEcCtD
Pazopanib—Insomnia—Docetaxel—stomach cancer	6.6e-05	0.000487	CcSEcCtD
Pazopanib—Paraesthesia—Docetaxel—stomach cancer	6.55e-05	0.000484	CcSEcCtD
Pazopanib—Alopecia—Methotrexate—stomach cancer	6.54e-05	0.000483	CcSEcCtD
Pazopanib—Bradycardia—Doxorubicin—stomach cancer	6.52e-05	0.000482	CcSEcCtD
Pazopanib—Dyspnoea—Docetaxel—stomach cancer	6.5e-05	0.00048	CcSEcCtD
Pazopanib—Somnolence—Docetaxel—stomach cancer	6.48e-05	0.000479	CcSEcCtD
Pazopanib—Mental disorder—Methotrexate—stomach cancer	6.48e-05	0.000479	CcSEcCtD
Pazopanib—Eye disorder—Epirubicin—stomach cancer	6.47e-05	0.000478	CcSEcCtD
Pazopanib—Erythema—Methotrexate—stomach cancer	6.44e-05	0.000476	CcSEcCtD
Pazopanib—Malnutrition—Methotrexate—stomach cancer	6.44e-05	0.000476	CcSEcCtD
Pazopanib—Haemoglobin—Doxorubicin—stomach cancer	6.44e-05	0.000476	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.43e-05	0.000475	CcSEcCtD
Pazopanib—Flushing—Epirubicin—stomach cancer	6.43e-05	0.000475	CcSEcCtD
Pazopanib—Cardiac disorder—Epirubicin—stomach cancer	6.43e-05	0.000475	CcSEcCtD
Pazopanib—Vomiting—Fluorouracil—stomach cancer	6.42e-05	0.000475	CcSEcCtD
Pazopanib—Dyspepsia—Docetaxel—stomach cancer	6.42e-05	0.000474	CcSEcCtD
Pazopanib—Haemorrhage—Doxorubicin—stomach cancer	6.41e-05	0.000473	CcSEcCtD
Pazopanib—Insomnia—Capecitabine—stomach cancer	6.39e-05	0.000472	CcSEcCtD
Pazopanib—Hypoaesthesia—Doxorubicin—stomach cancer	6.37e-05	0.000471	CcSEcCtD
Pazopanib—Rash—Fluorouracil—stomach cancer	6.37e-05	0.000471	CcSEcCtD
Pazopanib—Dermatitis—Fluorouracil—stomach cancer	6.37e-05	0.00047	CcSEcCtD
Pazopanib—Paraesthesia—Capecitabine—stomach cancer	6.34e-05	0.000468	CcSEcCtD
Pazopanib—Decreased appetite—Docetaxel—stomach cancer	6.34e-05	0.000468	CcSEcCtD
Pazopanib—Headache—Fluorouracil—stomach cancer	6.33e-05	0.000468	CcSEcCtD
Pazopanib—Urinary tract disorder—Doxorubicin—stomach cancer	6.33e-05	0.000467	CcSEcCtD
Pazopanib—ABCB1—endocrine gland—stomach cancer	6.32e-05	0.000658	CbGeAlD
Pazopanib—Oedema peripheral—Doxorubicin—stomach cancer	6.31e-05	0.000466	CcSEcCtD
Pazopanib—Dysgeusia—Methotrexate—stomach cancer	6.31e-05	0.000466	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Docetaxel—stomach cancer	6.3e-05	0.000465	CcSEcCtD
Pazopanib—Connective tissue disorder—Doxorubicin—stomach cancer	6.3e-05	0.000465	CcSEcCtD
Pazopanib—Dyspnoea—Capecitabine—stomach cancer	6.3e-05	0.000465	CcSEcCtD
Pazopanib—Fatigue—Docetaxel—stomach cancer	6.29e-05	0.000464	CcSEcCtD
Pazopanib—Angiopathy—Epirubicin—stomach cancer	6.28e-05	0.000464	CcSEcCtD
Pazopanib—Urethral disorder—Doxorubicin—stomach cancer	6.28e-05	0.000464	CcSEcCtD
Pazopanib—Nausea—Irinotecan—stomach cancer	6.27e-05	0.000463	CcSEcCtD
Pazopanib—Mediastinal disorder—Epirubicin—stomach cancer	6.24e-05	0.000461	CcSEcCtD
Pazopanib—Pain—Docetaxel—stomach cancer	6.24e-05	0.000461	CcSEcCtD
Pazopanib—Dyspepsia—Capecitabine—stomach cancer	6.22e-05	0.000459	CcSEcCtD
Pazopanib—Chills—Epirubicin—stomach cancer	6.21e-05	0.000459	CcSEcCtD
Pazopanib—Decreased appetite—Capecitabine—stomach cancer	6.14e-05	0.000453	CcSEcCtD
Pazopanib—Alopecia—Epirubicin—stomach cancer	6.12e-05	0.000452	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Capecitabine—stomach cancer	6.1e-05	0.00045	CcSEcCtD
Pazopanib—Fatigue—Capecitabine—stomach cancer	6.09e-05	0.00045	CcSEcCtD
Pazopanib—Vision blurred—Methotrexate—stomach cancer	6.07e-05	0.000448	CcSEcCtD
Pazopanib—Mental disorder—Epirubicin—stomach cancer	6.07e-05	0.000448	CcSEcCtD
Pazopanib—Pain—Capecitabine—stomach cancer	6.04e-05	0.000446	CcSEcCtD
Pazopanib—Erythema—Epirubicin—stomach cancer	6.03e-05	0.000445	CcSEcCtD
Pazopanib—Malnutrition—Epirubicin—stomach cancer	6.03e-05	0.000445	CcSEcCtD
Pazopanib—Nausea—Fluorouracil—stomach cancer	6e-05	0.000443	CcSEcCtD
Pazopanib—Eye disorder—Doxorubicin—stomach cancer	5.99e-05	0.000442	CcSEcCtD
Pazopanib—Gastrointestinal pain—Docetaxel—stomach cancer	5.96e-05	0.00044	CcSEcCtD
Pazopanib—Anaemia—Methotrexate—stomach cancer	5.95e-05	0.00044	CcSEcCtD
Pazopanib—Flushing—Doxorubicin—stomach cancer	5.95e-05	0.000439	CcSEcCtD
Pazopanib—Cardiac disorder—Doxorubicin—stomach cancer	5.95e-05	0.000439	CcSEcCtD
Pazopanib—Flatulence—Epirubicin—stomach cancer	5.94e-05	0.000439	CcSEcCtD
Pazopanib—Dysgeusia—Epirubicin—stomach cancer	5.9e-05	0.000436	CcSEcCtD
Pazopanib—Angiopathy—Doxorubicin—stomach cancer	5.81e-05	0.000429	CcSEcCtD
Pazopanib—Muscle spasms—Epirubicin—stomach cancer	5.8e-05	0.000428	CcSEcCtD
Pazopanib—Gastrointestinal pain—Capecitabine—stomach cancer	5.77e-05	0.000426	CcSEcCtD
Pazopanib—Mediastinal disorder—Doxorubicin—stomach cancer	5.77e-05	0.000426	CcSEcCtD
Pazopanib—Abdominal pain—Docetaxel—stomach cancer	5.77e-05	0.000426	CcSEcCtD
Pazopanib—Leukopenia—Methotrexate—stomach cancer	5.77e-05	0.000426	CcSEcCtD
Pazopanib—Chills—Doxorubicin—stomach cancer	5.75e-05	0.000425	CcSEcCtD
Pazopanib—ABCB1—liver—stomach cancer	5.69e-05	0.000594	CbGeAlD
Pazopanib—Vision blurred—Epirubicin—stomach cancer	5.68e-05	0.00042	CcSEcCtD
Pazopanib—Alopecia—Doxorubicin—stomach cancer	5.66e-05	0.000418	CcSEcCtD
Pazopanib—Cough—Methotrexate—stomach cancer	5.62e-05	0.000415	CcSEcCtD
Pazopanib—Mental disorder—Doxorubicin—stomach cancer	5.61e-05	0.000415	CcSEcCtD
Pazopanib—Abdominal pain—Capecitabine—stomach cancer	5.58e-05	0.000412	CcSEcCtD
Pazopanib—Erythema—Doxorubicin—stomach cancer	5.58e-05	0.000412	CcSEcCtD
Pazopanib—Malnutrition—Doxorubicin—stomach cancer	5.58e-05	0.000412	CcSEcCtD
Pazopanib—Anaemia—Epirubicin—stomach cancer	5.57e-05	0.000411	CcSEcCtD
Pazopanib—Flatulence—Doxorubicin—stomach cancer	5.5e-05	0.000406	CcSEcCtD
Pazopanib—Arthralgia—Methotrexate—stomach cancer	5.48e-05	0.000405	CcSEcCtD
Pazopanib—Myalgia—Methotrexate—stomach cancer	5.48e-05	0.000405	CcSEcCtD
Pazopanib—Chest pain—Methotrexate—stomach cancer	5.48e-05	0.000405	CcSEcCtD
Pazopanib—Dysgeusia—Doxorubicin—stomach cancer	5.46e-05	0.000403	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.45e-05	0.000402	CcSEcCtD
Pazopanib—Syncope—Epirubicin—stomach cancer	5.41e-05	0.000399	CcSEcCtD
Pazopanib—Leukopenia—Epirubicin—stomach cancer	5.4e-05	0.000398	CcSEcCtD
Pazopanib—Muscle spasms—Doxorubicin—stomach cancer	5.36e-05	0.000396	CcSEcCtD
Pazopanib—Loss of consciousness—Epirubicin—stomach cancer	5.3e-05	0.000391	CcSEcCtD
Pazopanib—Cough—Epirubicin—stomach cancer	5.26e-05	0.000388	CcSEcCtD
Pazopanib—Vision blurred—Doxorubicin—stomach cancer	5.26e-05	0.000388	CcSEcCtD
Pazopanib—Asthenia—Docetaxel—stomach cancer	5.23e-05	0.000386	CcSEcCtD
Pazopanib—Infection—Methotrexate—stomach cancer	5.22e-05	0.000386	CcSEcCtD
Pazopanib—Hypertension—Epirubicin—stomach cancer	5.2e-05	0.000384	CcSEcCtD
Pazopanib—Pruritus—Docetaxel—stomach cancer	5.16e-05	0.000381	CcSEcCtD
Pazopanib—Nervous system disorder—Methotrexate—stomach cancer	5.16e-05	0.000381	CcSEcCtD
Pazopanib—Anaemia—Doxorubicin—stomach cancer	5.15e-05	0.000381	CcSEcCtD
Pazopanib—Thrombocytopenia—Methotrexate—stomach cancer	5.15e-05	0.00038	CcSEcCtD
Pazopanib—Arthralgia—Epirubicin—stomach cancer	5.13e-05	0.000379	CcSEcCtD
Pazopanib—Myalgia—Epirubicin—stomach cancer	5.13e-05	0.000379	CcSEcCtD
Pazopanib—Chest pain—Epirubicin—stomach cancer	5.13e-05	0.000379	CcSEcCtD
Pazopanib—Skin disorder—Methotrexate—stomach cancer	5.11e-05	0.000377	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.1e-05	0.000376	CcSEcCtD
Pazopanib—Hyperhidrosis—Methotrexate—stomach cancer	5.08e-05	0.000375	CcSEcCtD
Pazopanib—Asthenia—Capecitabine—stomach cancer	5.07e-05	0.000374	CcSEcCtD
Pazopanib—Dry mouth—Epirubicin—stomach cancer	5.02e-05	0.000371	CcSEcCtD
Pazopanib—Anorexia—Methotrexate—stomach cancer	5.01e-05	0.00037	CcSEcCtD
Pazopanib—Syncope—Doxorubicin—stomach cancer	5e-05	0.000369	CcSEcCtD
Pazopanib—Pruritus—Capecitabine—stomach cancer	5e-05	0.000369	CcSEcCtD
Pazopanib—Leukopenia—Doxorubicin—stomach cancer	4.99e-05	0.000369	CcSEcCtD
Pazopanib—Diarrhoea—Docetaxel—stomach cancer	4.99e-05	0.000369	CcSEcCtD
Pazopanib—Oedema—Epirubicin—stomach cancer	4.92e-05	0.000363	CcSEcCtD
Pazopanib—Loss of consciousness—Doxorubicin—stomach cancer	4.9e-05	0.000362	CcSEcCtD
Pazopanib—Infection—Epirubicin—stomach cancer	4.89e-05	0.000361	CcSEcCtD
Pazopanib—Cough—Doxorubicin—stomach cancer	4.87e-05	0.000359	CcSEcCtD
Pazopanib—Shock—Epirubicin—stomach cancer	4.84e-05	0.000357	CcSEcCtD
Pazopanib—Diarrhoea—Capecitabine—stomach cancer	4.83e-05	0.000357	CcSEcCtD
Pazopanib—Nervous system disorder—Epirubicin—stomach cancer	4.82e-05	0.000356	CcSEcCtD
Pazopanib—Dizziness—Docetaxel—stomach cancer	4.82e-05	0.000356	CcSEcCtD
Pazopanib—Thrombocytopenia—Epirubicin—stomach cancer	4.82e-05	0.000356	CcSEcCtD
Pazopanib—Hypertension—Doxorubicin—stomach cancer	4.82e-05	0.000356	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.79e-05	0.000354	CcSEcCtD
Pazopanib—Skin disorder—Epirubicin—stomach cancer	4.78e-05	0.000353	CcSEcCtD
Pazopanib—Hyperhidrosis—Epirubicin—stomach cancer	4.76e-05	0.000351	CcSEcCtD
Pazopanib—Insomnia—Methotrexate—stomach cancer	4.75e-05	0.000351	CcSEcCtD
Pazopanib—Arthralgia—Doxorubicin—stomach cancer	4.75e-05	0.000351	CcSEcCtD
Pazopanib—Myalgia—Doxorubicin—stomach cancer	4.75e-05	0.000351	CcSEcCtD
Pazopanib—Chest pain—Doxorubicin—stomach cancer	4.75e-05	0.000351	CcSEcCtD
Pazopanib—Paraesthesia—Methotrexate—stomach cancer	4.72e-05	0.000349	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.72e-05	0.000348	CcSEcCtD
Pazopanib—Anorexia—Epirubicin—stomach cancer	4.69e-05	0.000346	CcSEcCtD
Pazopanib—Dyspnoea—Methotrexate—stomach cancer	4.69e-05	0.000346	CcSEcCtD
Pazopanib—Somnolence—Methotrexate—stomach cancer	4.67e-05	0.000345	CcSEcCtD
Pazopanib—Dizziness—Capecitabine—stomach cancer	4.67e-05	0.000345	CcSEcCtD
Pazopanib—Dry mouth—Doxorubicin—stomach cancer	4.64e-05	0.000343	CcSEcCtD
Pazopanib—Vomiting—Docetaxel—stomach cancer	4.64e-05	0.000342	CcSEcCtD
Pazopanib—Dyspepsia—Methotrexate—stomach cancer	4.63e-05	0.000342	CcSEcCtD
Pazopanib—Rash—Docetaxel—stomach cancer	4.6e-05	0.00034	CcSEcCtD
Pazopanib—Dermatitis—Docetaxel—stomach cancer	4.59e-05	0.000339	CcSEcCtD
Pazopanib—Decreased appetite—Methotrexate—stomach cancer	4.57e-05	0.000337	CcSEcCtD
Pazopanib—Headache—Docetaxel—stomach cancer	4.57e-05	0.000337	CcSEcCtD
Pazopanib—Oedema—Doxorubicin—stomach cancer	4.55e-05	0.000336	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Methotrexate—stomach cancer	4.54e-05	0.000335	CcSEcCtD
Pazopanib—Fatigue—Methotrexate—stomach cancer	4.53e-05	0.000335	CcSEcCtD
Pazopanib—Infection—Doxorubicin—stomach cancer	4.52e-05	0.000334	CcSEcCtD
Pazopanib—Pain—Methotrexate—stomach cancer	4.5e-05	0.000332	CcSEcCtD
Pazopanib—Vomiting—Capecitabine—stomach cancer	4.49e-05	0.000332	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.48e-05	0.000331	CcSEcCtD
Pazopanib—Shock—Doxorubicin—stomach cancer	4.48e-05	0.000331	CcSEcCtD
Pazopanib—Nervous system disorder—Doxorubicin—stomach cancer	4.46e-05	0.00033	CcSEcCtD
Pazopanib—Thrombocytopenia—Doxorubicin—stomach cancer	4.46e-05	0.000329	CcSEcCtD
Pazopanib—Rash—Capecitabine—stomach cancer	4.45e-05	0.000329	CcSEcCtD
Pazopanib—Insomnia—Epirubicin—stomach cancer	4.45e-05	0.000329	CcSEcCtD
Pazopanib—Dermatitis—Capecitabine—stomach cancer	4.45e-05	0.000329	CcSEcCtD
Pazopanib—Headache—Capecitabine—stomach cancer	4.42e-05	0.000327	CcSEcCtD
Pazopanib—Skin disorder—Doxorubicin—stomach cancer	4.42e-05	0.000327	CcSEcCtD
Pazopanib—Paraesthesia—Epirubicin—stomach cancer	4.42e-05	0.000326	CcSEcCtD
Pazopanib—Hyperhidrosis—Doxorubicin—stomach cancer	4.4e-05	0.000325	CcSEcCtD
Pazopanib—Dyspnoea—Epirubicin—stomach cancer	4.39e-05	0.000324	CcSEcCtD
Pazopanib—Somnolence—Epirubicin—stomach cancer	4.37e-05	0.000323	CcSEcCtD
Pazopanib—ABCB1—lymph node—stomach cancer	4.37e-05	0.000455	CbGeAlD
Pazopanib—Anorexia—Doxorubicin—stomach cancer	4.34e-05	0.00032	CcSEcCtD
Pazopanib—Nausea—Docetaxel—stomach cancer	4.33e-05	0.00032	CcSEcCtD
Pazopanib—Dyspepsia—Epirubicin—stomach cancer	4.33e-05	0.00032	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methotrexate—stomach cancer	4.3e-05	0.000317	CcSEcCtD
Pazopanib—Decreased appetite—Epirubicin—stomach cancer	4.28e-05	0.000316	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Epirubicin—stomach cancer	4.25e-05	0.000314	CcSEcCtD
Pazopanib—Fatigue—Epirubicin—stomach cancer	4.24e-05	0.000313	CcSEcCtD
Pazopanib—Pain—Epirubicin—stomach cancer	4.21e-05	0.000311	CcSEcCtD
Pazopanib—Nausea—Capecitabine—stomach cancer	4.19e-05	0.00031	CcSEcCtD
Pazopanib—Abdominal pain—Methotrexate—stomach cancer	4.16e-05	0.000307	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.15e-05	0.000306	CcSEcCtD
Pazopanib—Insomnia—Doxorubicin—stomach cancer	4.12e-05	0.000304	CcSEcCtD
Pazopanib—Paraesthesia—Doxorubicin—stomach cancer	4.09e-05	0.000302	CcSEcCtD
Pazopanib—Dyspnoea—Doxorubicin—stomach cancer	4.06e-05	0.0003	CcSEcCtD
Pazopanib—Somnolence—Doxorubicin—stomach cancer	4.05e-05	0.000299	CcSEcCtD
Pazopanib—Gastrointestinal pain—Epirubicin—stomach cancer	4.02e-05	0.000297	CcSEcCtD
Pazopanib—Dyspepsia—Doxorubicin—stomach cancer	4.01e-05	0.000296	CcSEcCtD
Pazopanib—Decreased appetite—Doxorubicin—stomach cancer	3.96e-05	0.000292	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.93e-05	0.00029	CcSEcCtD
Pazopanib—Fatigue—Doxorubicin—stomach cancer	3.92e-05	0.00029	CcSEcCtD
Pazopanib—Pain—Doxorubicin—stomach cancer	3.89e-05	0.000287	CcSEcCtD
Pazopanib—Abdominal pain—Epirubicin—stomach cancer	3.89e-05	0.000287	CcSEcCtD
Pazopanib—Asthenia—Methotrexate—stomach cancer	3.77e-05	0.000279	CcSEcCtD
Pazopanib—Gastrointestinal pain—Doxorubicin—stomach cancer	3.72e-05	0.000275	CcSEcCtD
Pazopanib—Pruritus—Methotrexate—stomach cancer	3.72e-05	0.000275	CcSEcCtD
Pazopanib—Abdominal pain—Doxorubicin—stomach cancer	3.6e-05	0.000266	CcSEcCtD
Pazopanib—Diarrhoea—Methotrexate—stomach cancer	3.6e-05	0.000266	CcSEcCtD
Pazopanib—Asthenia—Epirubicin—stomach cancer	3.53e-05	0.000261	CcSEcCtD
Pazopanib—Pruritus—Epirubicin—stomach cancer	3.48e-05	0.000257	CcSEcCtD
Pazopanib—Dizziness—Methotrexate—stomach cancer	3.48e-05	0.000257	CcSEcCtD
Pazopanib—Diarrhoea—Epirubicin—stomach cancer	3.37e-05	0.000249	CcSEcCtD
Pazopanib—Vomiting—Methotrexate—stomach cancer	3.34e-05	0.000247	CcSEcCtD
Pazopanib—Rash—Methotrexate—stomach cancer	3.31e-05	0.000245	CcSEcCtD
Pazopanib—Dermatitis—Methotrexate—stomach cancer	3.31e-05	0.000245	CcSEcCtD
Pazopanib—Headache—Methotrexate—stomach cancer	3.29e-05	0.000243	CcSEcCtD
Pazopanib—Asthenia—Doxorubicin—stomach cancer	3.27e-05	0.000241	CcSEcCtD
Pazopanib—Dizziness—Epirubicin—stomach cancer	3.25e-05	0.00024	CcSEcCtD
Pazopanib—Pruritus—Doxorubicin—stomach cancer	3.22e-05	0.000238	CcSEcCtD
Pazopanib—Vomiting—Epirubicin—stomach cancer	3.13e-05	0.000231	CcSEcCtD
Pazopanib—Nausea—Methotrexate—stomach cancer	3.12e-05	0.000231	CcSEcCtD
Pazopanib—Diarrhoea—Doxorubicin—stomach cancer	3.11e-05	0.00023	CcSEcCtD
Pazopanib—Rash—Epirubicin—stomach cancer	3.1e-05	0.000229	CcSEcCtD
Pazopanib—Dermatitis—Epirubicin—stomach cancer	3.1e-05	0.000229	CcSEcCtD
Pazopanib—Headache—Epirubicin—stomach cancer	3.08e-05	0.000228	CcSEcCtD
Pazopanib—Dizziness—Doxorubicin—stomach cancer	3.01e-05	0.000222	CcSEcCtD
Pazopanib—Nausea—Epirubicin—stomach cancer	2.92e-05	0.000216	CcSEcCtD
Pazopanib—Vomiting—Doxorubicin—stomach cancer	2.89e-05	0.000214	CcSEcCtD
Pazopanib—Rash—Doxorubicin—stomach cancer	2.87e-05	0.000212	CcSEcCtD
Pazopanib—Dermatitis—Doxorubicin—stomach cancer	2.87e-05	0.000212	CcSEcCtD
Pazopanib—Headache—Doxorubicin—stomach cancer	2.85e-05	0.000211	CcSEcCtD
Pazopanib—Nausea—Doxorubicin—stomach cancer	2.7e-05	0.0002	CcSEcCtD
Pazopanib—LCK—Disease—CDKN1A—stomach cancer	1.25e-06	7.46e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ERBB2—stomach cancer	1.25e-06	7.46e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—JUN—stomach cancer	1.25e-06	7.46e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK8—stomach cancer	1.25e-06	7.45e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALOX5—stomach cancer	1.24e-06	7.39e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.24e-06	7.37e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HRAS—stomach cancer	1.24e-06	7.36e-06	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—stomach cancer	1.24e-06	7.36e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6R—stomach cancer	1.23e-06	7.31e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HRAS—stomach cancer	1.23e-06	7.3e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PIK3CA—stomach cancer	1.22e-06	7.29e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HRAS—stomach cancer	1.22e-06	7.28e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—stomach cancer	1.22e-06	7.27e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DPYD—stomach cancer	1.22e-06	7.27e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PIK3CA—stomach cancer	1.22e-06	7.27e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—stomach cancer	1.22e-06	7.26e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CDKN1A—stomach cancer	1.22e-06	7.25e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HRAS—stomach cancer	1.22e-06	7.23e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTP1—stomach cancer	1.22e-06	7.23e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CDKN1A—stomach cancer	1.22e-06	7.23e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—stomach cancer	1.21e-06	7.23e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—STAT3—stomach cancer	1.21e-06	7.21e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KRAS—stomach cancer	1.21e-06	7.2e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ERCC2—stomach cancer	1.21e-06	7.17e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HMOX1—stomach cancer	1.2e-06	7.13e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KRAS—stomach cancer	1.2e-06	7.13e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PIK3CA—stomach cancer	1.2e-06	7.11e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—HRAS—stomach cancer	1.19e-06	7.1e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PIK3CA—stomach cancer	1.19e-06	7.09e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—stomach cancer	1.19e-06	7.08e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK8—stomach cancer	1.19e-06	7.07e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN1B—stomach cancer	1.19e-06	7.06e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK8—stomach cancer	1.19e-06	7.06e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—stomach cancer	1.18e-06	7.05e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—stomach cancer	1.18e-06	7.01e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—stomach cancer	1.17e-06	6.99e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—stomach cancer	1.17e-06	6.97e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.17e-06	6.95e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—PIK3CA—stomach cancer	1.17e-06	6.94e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—STAT3—stomach cancer	1.17e-06	6.94e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PIK3CA—stomach cancer	1.17e-06	6.93e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—stomach cancer	1.16e-06	6.93e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—stomach cancer	1.16e-06	6.92e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CD44—stomach cancer	1.16e-06	6.92e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN1B—stomach cancer	1.16e-06	6.91e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—MAPK3—stomach cancer	1.16e-06	6.89e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—stomach cancer	1.16e-06	6.88e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—stomach cancer	1.16e-06	6.88e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SERPINE1—stomach cancer	1.15e-06	6.85e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—stomach cancer	1.15e-06	6.82e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTP1—stomach cancer	1.15e-06	6.81e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—stomach cancer	1.14e-06	6.8e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HRAS—stomach cancer	1.13e-06	6.74e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—stomach cancer	1.13e-06	6.74e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCND1—stomach cancer	1.13e-06	6.73e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HRAS—stomach cancer	1.13e-06	6.72e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TYMS—stomach cancer	1.13e-06	6.72e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HMOX1—stomach cancer	1.13e-06	6.72e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—JUN—stomach cancer	1.13e-06	6.72e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.13e-06	6.71e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—stomach cancer	1.13e-06	6.71e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—stomach cancer	1.12e-06	6.66e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTM1—stomach cancer	1.12e-06	6.64e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAPK3—stomach cancer	1.11e-06	6.63e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PIK3CA—stomach cancer	1.11e-06	6.61e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RHOA—stomach cancer	1.11e-06	6.61e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCND1—stomach cancer	1.11e-06	6.59e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HRAS—stomach cancer	1.11e-06	6.58e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—JUN—stomach cancer	1.11e-06	6.58e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HRAS—stomach cancer	1.1e-06	6.56e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—MAPK1—stomach cancer	1.1e-06	6.56e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—EGFR—stomach cancer	1.1e-06	6.56e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PIK3CA—stomach cancer	1.1e-06	6.55e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—stomach cancer	1.1e-06	6.54e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—stomach cancer	1.1e-06	6.54e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—stomach cancer	1.1e-06	6.53e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—stomach cancer	1.1e-06	6.52e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN1A—stomach cancer	1.09e-06	6.51e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK3—stomach cancer	1.09e-06	6.51e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—stomach cancer	1.09e-06	6.47e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—stomach cancer	1.08e-06	6.45e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—stomach cancer	1.08e-06	6.45e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MYC—stomach cancer	1.08e-06	6.45e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—stomach cancer	1.08e-06	6.44e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTT1—stomach cancer	1.08e-06	6.43e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—HRAS—stomach cancer	1.08e-06	6.42e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HRAS—stomach cancer	1.08e-06	6.41e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—stomach cancer	1.08e-06	6.4e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—stomach cancer	1.08e-06	6.4e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN1A—stomach cancer	1.07e-06	6.38e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MAPK3—stomach cancer	1.07e-06	6.36e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK8—stomach cancer	1.07e-06	6.36e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.07e-06	6.35e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TYMS—stomach cancer	1.06e-06	6.33e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MYC—stomach cancer	1.06e-06	6.33e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAPK1—stomach cancer	1.06e-06	6.31e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EGFR—stomach cancer	1.06e-06	6.31e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—stomach cancer	1.06e-06	6.3e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—stomach cancer	1.06e-06	6.28e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTM1—stomach cancer	1.05e-06	6.26e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ERCC2—stomach cancer	1.05e-06	6.25e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK8—stomach cancer	1.05e-06	6.22e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAV1—stomach cancer	1.04e-06	6.22e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOA1—stomach cancer	1.04e-06	6.2e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK1—stomach cancer	1.04e-06	6.2e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EGFR—stomach cancer	1.04e-06	6.19e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—KRAS—stomach cancer	1.04e-06	6.19e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MYC—stomach cancer	1.04e-06	6.19e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.04e-06	6.18e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK3—stomach cancer	1.04e-06	6.18e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK3—stomach cancer	1.04e-06	6.16e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—stomach cancer	1.03e-06	6.15e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—stomach cancer	1.03e-06	6.14e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HRAS—stomach cancer	1.03e-06	6.12e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ERBB2—stomach cancer	1.03e-06	6.12e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HRAS—stomach cancer	1.02e-06	6.06e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MAPK1—stomach cancer	1.02e-06	6.05e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—EGFR—stomach cancer	1.02e-06	6.05e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ENO1—stomach cancer	1.01e-06	6.02e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MYC—stomach cancer	1.01e-06	6.01e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MYC—stomach cancer	1.01e-06	5.99e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KRAS—stomach cancer	1e-06	5.96e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.98e-07	5.94e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ERCC2—stomach cancer	9.89e-07	5.89e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPP2R1A—stomach cancer	9.89e-07	5.88e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK1—stomach cancer	9.88e-07	5.88e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EGFR—stomach cancer	9.88e-07	5.88e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—stomach cancer	9.87e-07	5.87e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—stomach cancer	9.87e-07	5.87e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK1—stomach cancer	9.86e-07	5.86e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EGFR—stomach cancer	9.86e-07	5.86e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—stomach cancer	9.84e-07	5.86e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KRAS—stomach cancer	9.84e-07	5.85e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—stomach cancer	9.77e-07	5.81e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—stomach cancer	9.75e-07	5.8e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—stomach cancer	9.74e-07	5.8e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTP1—stomach cancer	9.7e-07	5.77e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—stomach cancer	9.66e-07	5.75e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—KRAS—stomach cancer	9.61e-07	5.72e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HMOX1—stomach cancer	9.57e-07	5.69e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—PIK3CA—stomach cancer	9.56e-07	5.69e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—stomach cancer	9.56e-07	5.69e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN1B—stomach cancer	9.52e-07	5.66e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KRAS—stomach cancer	9.33e-07	5.55e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK3—stomach cancer	9.33e-07	5.55e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KRAS—stomach cancer	9.31e-07	5.54e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—stomach cancer	9.3e-07	5.53e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PIK3CA—stomach cancer	9.2e-07	5.47e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—stomach cancer	9.19e-07	5.47e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK3—stomach cancer	9.14e-07	5.44e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAV1—stomach cancer	9.1e-07	5.42e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOA1—stomach cancer	9.08e-07	5.4e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCND1—stomach cancer	9.08e-07	5.4e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MYC—stomach cancer	9.08e-07	5.4e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—JUN—stomach cancer	9.06e-07	5.39e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PIK3CA—stomach cancer	9.04e-07	5.38e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TYMS—stomach cancer	9.02e-07	5.37e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CD44—stomach cancer	8.98e-07	5.34e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTM1—stomach cancer	8.92e-07	5.3e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—stomach cancer	8.9e-07	5.3e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MYC—stomach cancer	8.89e-07	5.29e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK1—stomach cancer	8.88e-07	5.28e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGFR—stomach cancer	8.88e-07	5.28e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—HRAS—stomach cancer	8.85e-07	5.26e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PIK3CA—stomach cancer	8.83e-07	5.25e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—stomach cancer	8.82e-07	5.25e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN1A—stomach cancer	8.79e-07	5.23e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—stomach cancer	8.74e-07	5.2e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK1—stomach cancer	8.69e-07	5.17e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGFR—stomach cancer	8.69e-07	5.17e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAV1—stomach cancer	8.58e-07	5.1e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PIK3CA—stomach cancer	8.58e-07	5.1e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK8—stomach cancer	8.58e-07	5.1e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOA1—stomach cancer	8.56e-07	5.09e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PIK3CA—stomach cancer	8.55e-07	5.09e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HRAS—stomach cancer	8.51e-07	5.06e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—stomach cancer	8.47e-07	5.04e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PIK3CA—stomach cancer	8.44e-07	5.02e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KRAS—stomach cancer	8.39e-07	4.99e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ERCC2—stomach cancer	8.38e-07	4.99e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HRAS—stomach cancer	8.36e-07	4.97e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—stomach cancer	8.3e-07	4.94e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—stomach cancer	8.27e-07	4.92e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—stomach cancer	8.26e-07	4.91e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KRAS—stomach cancer	8.21e-07	4.89e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—HRAS—stomach cancer	8.17e-07	4.86e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—stomach cancer	8.15e-07	4.85e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—stomach cancer	8e-07	4.76e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—stomach cancer	8e-07	4.76e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HRAS—stomach cancer	7.93e-07	4.72e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—stomach cancer	7.92e-07	4.71e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HRAS—stomach cancer	7.91e-07	4.71e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—stomach cancer	7.9e-07	4.7e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—stomach cancer	7.88e-07	4.69e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—stomach cancer	7.84e-07	4.66e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—stomach cancer	7.82e-07	4.65e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3CA—stomach cancer	7.74e-07	4.6e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CA—stomach cancer	7.71e-07	4.58e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPP2R1A—stomach cancer	7.63e-07	4.54e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—stomach cancer	7.59e-07	4.52e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—stomach cancer	7.57e-07	4.51e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CA—stomach cancer	7.54e-07	4.49e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—stomach cancer	7.54e-07	4.49e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK3—stomach cancer	7.49e-07	4.46e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTP1—stomach cancer	7.49e-07	4.45e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—stomach cancer	7.45e-07	4.44e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HMOX1—stomach cancer	7.38e-07	4.39e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—stomach cancer	7.3e-07	4.34e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MYC—stomach cancer	7.28e-07	4.33e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAV1—stomach cancer	7.27e-07	4.32e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOA1—stomach cancer	7.25e-07	4.31e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—stomach cancer	7.23e-07	4.3e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—stomach cancer	7.2e-07	4.28e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CA—stomach cancer	7.16e-07	4.26e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HRAS—stomach cancer	7.13e-07	4.24e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK1—stomach cancer	7.13e-07	4.24e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGFR—stomach cancer	7.13e-07	4.24e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HRAS—stomach cancer	6.98e-07	4.15e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TYMS—stomach cancer	6.96e-07	4.14e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.94e-07	4.13e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—stomach cancer	6.88e-07	4.1e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTM1—stomach cancer	6.88e-07	4.09e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—stomach cancer	6.82e-07	4.06e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—stomach cancer	6.78e-07	4.03e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KRAS—stomach cancer	6.73e-07	4e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—stomach cancer	6.68e-07	3.97e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—stomach cancer	6.49e-07	3.86e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ERCC2—stomach cancer	6.47e-07	3.85e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—stomach cancer	6.39e-07	3.8e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—stomach cancer	6.3e-07	3.75e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CA—stomach cancer	6.18e-07	3.68e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—stomach cancer	6.08e-07	3.62e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—stomach cancer	5.98e-07	3.56e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—stomach cancer	5.93e-07	3.53e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—stomach cancer	5.74e-07	3.42e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HRAS—stomach cancer	5.72e-07	3.4e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAV1—stomach cancer	5.61e-07	3.34e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOA1—stomach cancer	5.6e-07	3.33e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—stomach cancer	5.5e-07	3.27e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—stomach cancer	5.48e-07	3.26e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—stomach cancer	5.03e-07	2.99e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—stomach cancer	4.93e-07	2.93e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CA—stomach cancer	4.45e-07	2.65e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—stomach cancer	4.43e-07	2.64e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—stomach cancer	4.24e-07	2.52e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—stomach cancer	3.88e-07	2.31e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CA—stomach cancer	3.87e-07	2.3e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.65e-07	2.17e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CA—stomach cancer	3.09e-07	1.84e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.39e-07	1.42e-06	CbGpPWpGaD
